Kavalactones, A novel class of protein glycation and lipid peroxidation inhibitors

Planta Medica

Volumn 80, Issue 12, 2014, Pages 1001-1008

  Upadhyay, Atul ^a   Tuenter, Emmy ^a   Ahmad, Rizwan ^a   Amin, Adnan ^a   Exarchou, Vasiliki ^a   Apers, Sandra ^a   Hermans, Nina ^a   Pieters, Luc ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

advanced glycation endproducts (AGEs); advanced lipoxidation endproducts (ALEs) kavalactones; Caenorhabditis elegans; chelation; kawain

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; CARBONYL DERIVATIVE; COPPER; DIHYDROMETHYSTICIN; GLUCOSE; GLYOXAL; IRON; KAWAIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; METHYSTICIN; THIOBARBITURIC ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; 7,8-DIHYDROMETHYSTICIN; CHELATING AGENT; GUANIDINE DERIVATIVE; LACTONE; PLANT EXTRACT; PYRAN DERIVATIVE; PYRONE DERIVATIVE;

ANTIOXIDANT ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; CHELATION; FLUORESCENCE; LIFE EXTENSION; LIPID PEROXIDATION; OXIDATION; PROTEIN GLYCOSYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GLYCOSYLATION; LONGEVITY; METABOLISM; OXIDATIVE STRESS;

CAENORHABDITIS ELEGANS;

ANIMALS; CAENORHABDITIS ELEGANS; CHELATING AGENTS; GLUCOSE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; LACTONES; LINOLEIC ACID; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LONGEVITY; OXIDATIVE STRESS; PLANT EXTRACTS; PYRANS; PYRONES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84906937192     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0034-1382949     Document Type: Article

References (28)

1. Schmidt A. M., Hori O., Brett J., Yan S. D., Wautier J. L., Stern D. Cellular receptors for advanced glycation endproducts. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb: 1994; 14 1521 1528
2. Munch G., Thome J., Foley P., Schinze R., Riederer P. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Rev: 1997; 23 134 143 (Pubitemid 27090752)
3. Baynes J. W. Pyridoxamie, a versatile inhibitor of advanced glycation and lipoxidation reactions. Int Congr Ser: 2002; 1245 31 35
4. Basta G., Schmidt A. M., Caterina R. D. Avanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res: 2004; 63 582 592 (Pubitemid 39078671)
5. Heijst J. WJV, Niessen H. WM, Hoekman K., Schalkwijk C. G. Advanced glycation end products in human cancer tissues. Ann N Y Acad Sci: 2006; 1043 725 733
6. Negre-Salvayre A., Auge N., Ayala V., Basaga H., Boada J., Brenke R., Chapple S., Cohen G., Feher J., Grune T., Lengyel G., Mann G. E., Pamplona R., Poli G., Portero-Otin M., Riahi Y., Salvayre R., Sasson S., Serrano J., Shamni O., Siems W., Siow R. CM, Wiswedel I., Zarkovic K., Zarkovic N. Pathological aspects of lipid peroxidation. Free Radic Res: 2010; 44 1125 1171
7. Boerner R. J., Sommer H., Berger W., Kuhn U., Schmidt U., Mannel M. Kava-kava extract LI 150 is as effective as opipramol and buspirone in generalised anxiety disorder - an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. Phytomedicine: 2003; 10 Suppl. 4 38 49 (Pubitemid 36597155)
8. Upadhyay A., Chompoo J., Kishimoto W., Makise T., Tawata S. HIV-1 integrase and neuraminidase inhibitors from Alpinia zerumbet. J Agric Food Chem: 2011; 59 2857 2862
9. Xuan T. D., Fukuta M., Wei A. C., Elzaawely A. A., Khanh T. D., Tawata S. Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots. J Nat Med: 2008; 62 188 194 (Pubitemid 351365814)
10. Chompoo J., Upadhyay A., Kishimoto W., Makise T., Tawata S. Advanced glycation end products inhibitors from Alpinia zerumbet rhizomes. Food Chem: 2011; 129 709 715
11. Hidalgo F. J., Zamora R. Interplay between the maillard reaction and lipid peroxidation in biochemical systems. Ann N Y Acad Sci: 2005; 1043 319 326 (Pubitemid 41123921)
12. Rahbar S. Novel inhibitors of glycation and AGE formation. Cell Biochem Biophys: 2007; 48 147 157 (Pubitemid 47340881)
13. Harris C. S., Beaulieu L. P., Fraser M. H., McIntyre K. L., Owen P. L., Martineau L. C., Cuerrier A., Johns T., Haddad P. S., Bennett A. L., Arnason J. T. Inhibition of advanced glycation end product formation by medicinal plant extracts correlated with phenolic metabolites and antioxidant activity. Planta Med: 2011; 77 196 204
14. Pashikanti S., De Alba D. R., Boissonneault G. A., Cervantes-Laurean D. Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products. Free Rad Biol Med: 2010; 48 656 663
15. Morel S., Helesbeux J. J., Séraphin D., Derbré S., Gatto J., Aumond M. C., Abatuci Y., Grellier P., Beniddir M. A., Le Pape P., Pagniez F., Litaudon M., Landreau A., Richomme P. Anti-AGEs and antiparasitic activity of an original prenylated isoflavonoid and flavanones isolated from Derris ferruginea. Phytochemistry Lett: 2013; 6 498 503
16. Rahbar S., Natarajan R., Yerneni K. K., Scott S., Gonzales N., Nadler J. L. Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation. Clin Chim Acta: 2000; 301 65 77
17. Brownlee M. Biochemistry and molecular biology of diabetic complications. Nature: 2001; 414 813 820 (Pubitemid 34000785)
18. Voziyan P. A., Metz T. O., Baynes J. W., Hudso B. G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem: 2002; 277 3397 3403 (Pubitemid 34953208)
19. Nagai R., Murray D. B., Metz T. O., Baynes J. W. Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes: 2012; 61 549 559
20. Price D. L., Rhett P. M., Thorpe S. R., Baynes J. W. Chelating activity of advanced glycation end-product inhibitors. J Biol Chem: 2001; 276 48967 48972
21. Sajithlal G. B., Chithra P., Chandrakasan G. The role of metal catalysed oxidation in the formation of advanced glycation end products: an in vitro study on collagen. Free Rad Biol Med: 1998; 25 265 269 (Pubitemid 28326200)
22. Onorato J. M., Jenkins A. J., Thorpe S. R., Baynes J. W. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. J Biol Chem: 2000; 275 21177 21184 (Pubitemid 30481811)
23. Miyata T., Ueda Y., Asahi K., Izuhara Y., Inagi R., Saito A., van Ypersele de Strihou C., Kurokawa K. Mechanism of the inhibitory effect of OPB-9195 [(±)-2-isopropylidenehydrazoneo-4-oxo-thaizolidin-5- ylactenilide] on advanced glycation endproduct and advanced lipoxidation end product formation. J Am Soc Nephrol: 2000; 11 1719 1725
24. Schlotterer A., Kukudov G., Bozorgmehr F., Hutter H., Du X., Oikonomou D., Ibrahim Y., Pfisterer F., Rabbani N., Thornalley P., Sayed A., Fleming T., Humpert P., Schwenger V., Zeier M., Hamann A., Stern D., Brownlee M., Bierhaus A., Nawroth P. C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes: 2009; 58 2450 2456
25. Reddy V. P., Garrett M. R., Perry G., Smith M. A. Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowl Environ: 2005; 2005 12
26. Buettner G. R. In the absence of catalytic metals ascorbate does not autoxidize at pH7: ascorbate as a test for catalytic metals. J Biochem Biophys Methods: 1988; 16 27 40
27. Wallin B., Rosengren B., Shertzer H. G., Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal Biochem: 1993; 208 10 15 (Pubitemid 23086994)
28. Upadhyay A., Chompoo J., Taira N., Fukuta M., Tawata S. Significant longevity-extending effects of Alpinia zerumbet leaf extracts on the life span of Caenorhabditis elegans. Biosci Biotechnol Biochem: 2013; 77 217 223